Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tyrosur is a topical wound-healing medicinal product line containing the polypeptide antibiotic tyrothricin (in Tyrosur Wound Healing Gel and Tyrosur Wound Healing Powder) and, in a separate non‑antibiotic variant, dexpanthenol (Tyrosur CareExpert Wound Gel). It is used for the alleviating treatment of small, superficial, lightly exudative or non‑weeping skin wounds with bacterial superinfection, such as lacerations, scratches, abrasions, and other minor inflamed wounds, where the hydrogel base maintains a moist environment while the locally acting tyrothricin exerts broad‑spectrum antibacterial activity against tyrothricin‑sensitive pathogens, thereby reducing infection and supporting granulation, epithelization, and overall wound healing in adults and children.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tyrosur.